Tempest Therapeutics (TPST) EV to FCF (2012 - 2025)

Tempest Therapeutics has disclosed EV to FCF across 14 years of filings, most recently posting 1.8 for Q4 2025.

• In Q4 2025, EV to FCF fell 361.77% year-over-year to 1.8; the TTM figure through Dec 2025 stood at 0.24 (down 214.98% YoY), while the FY2025 annual figure was 0.24, down 214.98% from the prior year.
• EV to FCF came in at 1.8 for Q4 2025 at Tempest Therapeutics, up from 5.62 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 6.85 in Q1 2021 to a low of 1019.51 in Q2 2021.
• Average EV to FCF over 5 years is 51.03, with a median of 1.25 recorded in 2023.
• Year-over-year, EV to FCF jumped 265.15% in 2021 and sank 1665.01% in 2024.
• Over 5 years, EV to FCF stood at 5.84 in 2021, then plunged by 50.97% to 2.87 in 2022, then sank by 261.45% to 4.63 in 2023, then jumped by 114.87% to 0.69 in 2024, then sank by 361.77% to 1.8 in 2025.
• Per Business Quant data, the three most recent EV to FCF figures were 1.8 in Q4 2025, 5.62 in Q3 2025, and 1.88 in Q2 2025.